Saaya Tsutsué

Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphoma

B. Crawford, Saaya Tsutsué, S. Makita, 2021, Future oncology.

Cost drivers associated with diffuse large B-cell lymphoma (DLBCL) in Japan: A structural equation model (SEM) analysis

B. Crawford, Saaya Tsutsué, S. Makita, 2022, PloS one.

Real-world assessment of myelodysplastic syndrome: Japanese claims data analysis.

Takahiro Suzuki, B. Crawford, Saaya Tsutsué, 2021, Future oncology.

Comparative effectiveness study of chemotherapy in follicular lymphoma patients in the rituximab era: a Japanese claims database study.

K. Tobinai, B. Crawford, Saaya Tsutsué, 2020, Future oncology.

Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma

K. Tobinai, B. Crawford, Saaya Tsutsué, 2020, PloS one.

Cost-effectiveness analysis 3L of axicabtagene ciloleucel vs tisagenlecleucel and lisocabtagene maraleucel in Japan.

Saaya Tsutsué, Shinichi Makita, Hiroya Asou, 2024, Future oncology.